Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Price : 45.11 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 47.71 | 47.82 | 45.79 | 45.85 | 748894.0 |
| Aug 20, 2026 | 47.86 | 48.26 | 46.93 | 47.45 | 646851.0 |
| Aug 19, 2026 | 49.50 | 49.82 | 48.51 | 48.54 | 797224.0 |
| Aug 18, 2026 | 48.80 | 49.57 | 48.54 | 49.03 | 592240.0 |
| Aug 17, 2026 | 47.66 | 48.66 | 47.66 | 48.27 | 536730.0 |
| Aug 14, 2026 | 46.70 | 48.39 | 46.57 | 48.27 | 331732.0 |
| Aug 13, 2026 | 47.74 | 48.18 | 46.87 | 47.15 | 667872.0 |
| Aug 12, 2026 | 47.15 | 47.92 | 46.26 | 47.87 | 667316.0 |
| Aug 11, 2026 | 47.01 | 48.60 | 46.77 | 46.88 | 669685.0 |
| Aug 10, 2026 | 47.11 | 47.72 | 46.47 | 47.07 | 762175.0 |
| Aug 07, 2026 | 47.00 | 47.88 | 46.43 | 47.64 | 702627.0 |
| Aug 06, 2026 | 47.82 | 48.40 | 46.55 | 46.76 | 1.345M |
| Aug 05, 2026 | 42.95 | 47.89 | 42.91 | 46.91 | 1.672M |
| Aug 04, 2026 | 46.23 | 46.58 | 42.62 | 43.25 | 3.706M |
| Aug 03, 2026 | 50.45 | 52.50 | 44.17 | 46.00 | 4.519M |
| Jul 31, 2026 | 45.19 | 45.67 | 44.35 | 44.63 | 573626.0 |
| Jul 30, 2026 | 46.30 | 46.77 | 45.50 | 45.61 | 468740.0 |
| Jul 29, 2026 | 47.60 | 48.00 | 46.08 | 46.57 | 522131.0 |
| Jul 28, 2026 | 47.78 | 48.45 | 46.77 | 47.73 | 538195.0 |
| Jul 27, 2026 | 46.56 | 48.08 | 45.84 | 46.98 | 523013.0 |
| Jul 24, 2026 | 47.02 | 47.46 | 46.03 | 46.20 | 521936.0 |
| Jul 23, 2026 | 46.41 | 47.54 | 46.07 | 47.19 | 463337.0 |
| Jul 22, 2026 | 47.87 | 48.12 | 46.79 | 46.94 | 430060.0 |
| Jul 21, 2026 | 47.00 | 48.02 | 46.39 | 47.87 | 450290.0 |
| Jul 20, 2026 | 48.09 | 48.79 | 47.30 | 47.42 | 618821.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Indivior Pharmaceuticals, Inc. | 36.18 |
| Pfizer Inc. | 27.98 |
| Amphastar Pharmaceuticals, Inc. | 21.51 |
| Collegium Pharmaceutical, Inc. | 27.39 |
| Bristol Myers Squibb Co. | 67.31 |
Price Related Metrics
| PS Ratio | 3.118 |
| Price to Book Value | 2.544 |
| Price to Free Cash Flow | 137.83 |
| Earnings Yield | -4.24% |
| Market Cap | 2.624B |